Gritstone Oncology
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $57 | $49 | $29 | $1,565 |
Gross Profit | -1,543 | -1,693 | -1,892 | -399 |
EBITDA | -26,852 | -39,752 | -38,904 | -38,604 |
EBIT | -28,452 | -41,494 | -40,825 | -40,568 |
Net Income | -23,396 | -40,385 | -30,818 | -38,434 |
Net Change In Cash | 57 | 49 | 29 | 1,565 |
Free Cash Flow | -26,843 | -33,710 | -34,566 | -32,180 |
Cash | 52,174 | 43,642 | 65,285 | 29,539 |
Basic Shares | 143,296 | 118,391 | 97,585 | 115,342 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,331 | $9,269 | $46,717 | $4,037 |
Gross Profit | -6,260 | -6,422 | 32,318 | -84,606 |
EBITDA | -147,043 | -118,452 | -68,862 | -99,373 |
EBIT | -154,634 | -134,143 | -83,261 | -106,017 |
Net Income | -138,490 | -113,127 | -74,955 | -104,611 |
Net Change In Cash | 1,331 | 9,269 | 46,717 | 4,037 |
Cost of Revenue | -45,812 | -60,471 | 112,648 | |
Free Cash Flow | -126,220 | -121,818 | -56,141 | -92,617 |
Cash | 65,285 | 55,498 | 93,287 | 170,056 |
Basic Shares | 115,527 | 90,918 | 78,885 | 37,792 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.16 |
2024-03-31 | -$0.34 |
2023-12-31 | -$0.26 |
2023-09-30 | -$0.33 |
